A global metabolite-mediated architecture with the capacity to coordinate proteins across otherwise distinct cellular systems is revealed and experimentally established metabolite-dependent complexes validate the local mechanism independently of LIGMAP.
Abstract
Metabolites are substrates, products, cofactors, and regulators, but protein–protein interaction networks do not represent their potential to organize proteins across conventional pathway boundaries. Using the LIGMAP virtual-screening algorithm, we mapped 308 human metabolite codes to pockets in monomers, dimer interfaces, and non-interface sites in dimers and represented attractive or repulsive COLIG states involving pairs of metabolites in the same pocket. On a fixed cohort of 3,938 proteins, the mean coverage of 104 strict non-enzyme pathways was 44.6% for LIGMAP, 70.1% for STRING, and 82.5% for STRING+LIGMAP; the union placed 86.3% of eligible proteins in the largest connected component and 95.1% in the two largest components. STRING+LIGMAP protein coverage was 88.0% for 68 enzyme-only pathways and 88.9% for 1,283 mixed pathways. In pathway-held-out, degree-matched prediction, adding LIGMAP to degree plus STRING increased the mean area under the precision–recall curve from 0.651 to 0.660 (paired P = 0.024); adding BioLiP2 increased it to 0.663 (paired P = 0.005). Ancient-only and non-ancient-only subnetworks were each globally connected; ancient features were denser, whereas non-ancient features covered more proteins and pathways. At the full 5,426-protein scale, retaining only features assigned to 2–100 proteins recovered 698 of 1,691 strict non-enzyme reference edges (41.3%) and exceeded both protein-label and exact bipartite degree-preserving nulls. Uncapped recovery approached saturation and lost identity-selective enrichment. Experimentally established metabolite-dependent complexes validate the local mechanism independently of LIGMAP; LIGMAP fully recovered two of seven stringent direct mechanisms and all three broader serial axes examined. Our findings reveal a global metabolite-mediated architecture with the capacity to coordinate proteins across otherwise distinct cellular systems.
Metabolites are generally viewed as substrates, products, cofactors, or regulators of individual proteins, whereas metabolites recurring across many protein families are often regarded as promiscuous binders. Here, we analyzed 989,058 BioLiP2 protein–ligand binding sites and assigned 929,546 sites to ECOD v295 homologo...
A framework for accelerating the development of next-generation PPI therapeutics is provided by connecting interface architecture with optimal inhibitor modality and discovery strategy, revealing clear links between interface topology and inhibitor discovery strategies.
Ellie Hyde, A. Beekman· RSC Medicinal Chemistry· 0 citations
Whether AlphaFold 3 complex prediction, combined with STRING evidence and domain-level analysis of interfaces and interaction partners, can help identify and characterize DUF-containing proteins and suggest roles for DUF4130 in nucleic-acid-associated radical-SAM biology and DUF5819 in a bacterial system related to vit...
Lino Riepenhausen, Francesco Costa, Antonina Andreeva et al.· bioRxiv· 0 citations
LoGoPPI is presented, which infers PPIs from sequence by combining bi-encoder global protein representation with local residue-level late interaction, and provides a scalable framework for comparative and functional analysis of protein networks across diverse taxa.
H. Lee, Junyeong Ma, Han-June Kim et al.· bioRxiv· 0 citations
Accurate identification of protein-protein interactions (PPIs) is fundamental for understanding cellular mechanisms and facilitating drug discovery. Although high-throughput experimental methods have expanded the known interactome, they remain resourceintensive and prone to noise. Consequently, computational approaches...
Pantelis Makrygiannis, Nikitas-Rigas Kalogeropoulos, Agorakis Bompotas et al.· International journal on art...· 0 citations
The fragment molecular orbital (FMO) quantum mechanics method offers a comprehensive and computationally inexpensive means of identifying the strength and the chemical nature of the molecular interactions taking place at the protein-protein interface of large biomolecular systems.
Dustin C. Woods, Stefania Monteleone, Stéphanie Labouille· Methods in molecular biology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.